The European Medicines Agency (EMA) is a decentralised agency of the European Union (EU). It began operating in 1995. The Agency is responsible for the scientific evaluation, supervision and safety monitoring of medicines in the EU.
EMA protects public and animal health in EU Member States, as well as the countries of the European Economic Area, by ensuring that all medicines available on the EU market are safe, effective and of high quality.
EMA serves a community of around 450 million people living in the EU.
EMA routinely gathers stakeholder feedback on its communication activities via communication perception surveys.
The findings help EMA set targets, address areas for improvement and measure progress in the area of communication.
EMA has been capturing the results of its communication perception surveys in report format since 2017.
Please note that no report is available on the 2020 survey, due to impact on EMA of the COVID-19 pandemic.